RDDT Form 4: Huffman Discloses 18,000-Share Sales and Option Grant
Rhea-AI Filing Summary
Steve L. Huffman, CEO & President of Reddit, Inc. (RDDT), reported multiple transactions on 09/15/2025. The filing shows an award of a stock option for 18,000 shares with a $25.29 exercise price that vests quarterly over five years and expires 12/25/2033. The report also discloses a series of open-market sales of Class A common stock totaling 18,000 shares executed under a Rule 10b5-1 trading plan adopted May 19, 2025, at weighted-average prices ranging from $256.11 up to $265.38 across multiple tranches. Following these transactions, beneficial ownership reported for the issuer decreased from 512,104 to 494,104 Class A shares held indirectly by The XYZ Revocable Trust.
Positive
- Option grant disclosed for 18,000 shares at $25.29 with a multi-year vesting schedule, clarifying compensation terms
- Sales executed under a Rule 10b5-1 plan, indicating trades were pre-planned and intended to provide an affirmative defense
Negative
- Beneficial ownership decreased
- Multiple tranches of sales at market prices could be interpreted as liquidity-taking by the reporting person
Insights
TL;DR: Insider sold 18,000 shares under a 10b5-1 plan while receiving an 18,000-share option grant; overall holdings fell modestly.
These transactions combine an option grant and contemporaneous sales of equal aggregate share count, which is consistent with routine compensation and liquidity management under a pre-established trading plan. The sales were executed across multiple price bands with the filer offering to provide trade-level detail on request. The decrease in reported beneficial Class A holdings is roughly 3.6% of the starting 512,104 shares, a change that is material to insider position sizing but small relative to typical public float metrics.
TL;DR: Use of a Rule 10b5-1 plan and disclosure of vesting schedule aligns with governance best practices.
The filing discloses that sales were executed pursuant to a Rule 10b5-1 plan adopted on May 19, 2025, which provides an affirmative defense for pre-planned trades. The option award includes a clear vesting schedule tied to continued service, and the filing is signed by an attorney-in-fact, indicating proper execution of Form 4 processes. No departures, policy breaches, or unusual derivative structures are disclosed.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Stock Option (Right to Buy) | 18,000 | $0.00 | -- |
| Exercise | Class A Common Stock | 18,000 | $0.00 | -- |
| Sale | Class A Common Stock | 1,100 | $256.69 | $282K |
| Sale | Class A Common Stock | 2,152 | $257.64 | $554K |
| Sale | Class A Common Stock | 1,800 | $258.95 | $466K |
| Sale | Class A Common Stock | 2,458 | $259.93 | $639K |
| Sale | Class A Common Stock | 1,576 | $260.98 | $411K |
| Sale | Class A Common Stock | 2,349 | $262.12 | $616K |
| Sale | Class A Common Stock | 2,200 | $263.34 | $579K |
| Sale | Class A Common Stock | 3,197 | $264.08 | $844K |
| Sale | Class A Common Stock | 1,168 | $265.00 | $310K |
Footnotes (1)
- The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 19, 2025. The sales were executed in multiple trades at prices ranging from $256.11 to $257.06. The price reported reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price within the ranges set forth in footnotes (2) to (10) to this Form 4. The sales were executed in multiple trades at prices ranging from $257.14 to $258.10. The sales were executed in multiple trades at prices ranging from $258.47 to $259.43. The sales were executed in multiple trades at prices ranging from $259.47 to $260.45. The sales were executed in multiple trades at prices ranging from $260.53 to $261.47. The sales were executed in multiple trades at prices ranging from $261.63 to $262.52. The sales were executed in multiple trades at prices ranging from $262.65 to $263.64. The sales were executed in multiple trades at prices ranging from $263.65 to $264.59. The sales were executed in multiple trades at prices ranging from $264.65 to $265.38. The option vests over five years on each quarterly anniversary of December 25, 2023, subject to the Reporting Person's continued employment or service relationship with the Issuer on each such vesting date.